课题基金 / 基金详情

VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced Genomics

VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced Genomics
VANTAGE:整合创建范德比尔特先进基因组学技术
批准号:
7935727
负责人:
JENNIFER A PIETENPOL
金额:
$867.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-25 至 2013-09-30

项目摘要

项目成果

JENNIFER A PIETENPOL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Recognizing the importance of translating advances in genome science to improved human health, Vanderbilt University School of Medicine has made a commitment to provide state-of-the art laboratory environments and technology through shared resource facilities. To that end, the purpose of this grant application is to optimize an environment conducive to collaboration and acceleration of new biological and clinical discoveries through consolidation of multiple currently physically separate research resources into a centrally located shared resource: VANTAGE (VANderbilt Technologies for Advanced GEnomics). Through complete modernization of an existing 9,316 Net Square Feet of aging, poorly-utilized laboratory space, this proposal will create a physical home for the Genome Technology Core (GTC, a collaborative core for development of next-generation technologies) and BioVU (the Vanderbilt DNA Repository currently housed within the DNA Resources Core), and will enable the consolidation and expansion of four existing core facilities: DNA Resources Core, DNA Sequencing Core, Vanderbilt Microarray Shared Resource (VMSR) and the Flow Cytometry Core. Once renovation is complete, each of these distinct research resources will share collaborative space, thereby creating an institutional nexus of discovery in genomics research by extending and strengthening already successful collaborations. VANTAGE will enable technical synergy, eliminate unnecessary duplication and accelerate discovery in clinical and basic science across the institution. In particular, this renovation will impact over 968 active grants from major Vanderbilt users involving approximately 235 million in annual direct costs.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
A guide to single-cell RNA sequencing analysis using web-based tools for non-bioinformatician.
面向非生物信息学家的使用基于网络的工具进行单细胞 RNA 测序分析的指南。
DOI: 10.1111/febs.17036
发表时间: 2023
期刊: The FEBS journal
影响因子: --
作者: [Yarlagadda,Sagnik, Giorgio,ToddD]
通讯作者: Giorgio,ToddD
DOI: 10.3390/ijms21218250
发表时间: 2020-11-04
期刊: International journal of molecular sciences
影响因子: 5.6
作者: [Pannala VR, Estes SK, Rahim M, Trenary I, O'Brien TP, Shiota C, Printz RL, Reifman J, Shiota M, Young JD, Wallqvist A]
通讯作者: Wallqvist A
DOI: 10.3390/ijms24087434
发表时间: 2023-04-18
期刊: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子: 5.6
作者: [Goel, Himanshu, Printz, Richard L., Shiota, Chiyo, Estes, Shanea K., Pannala, Venkat, AbdulHameed, Mohamed Diwan M., Shiota, Masakazu, Wallqvist, Anders]
通讯作者: Wallqvist, Anders
DOI: 10.1038/s41598-018-24488-8
发表时间: 2018-04-17
期刊: Scientific reports
影响因子: 4.6
作者: [Saxon JA, Yu H, Polosukhin VV, Stathopoulos GT, Gleaves LA, McLoed AG, Massion PP, Yull FE, Zhao Z, Blackwell TS]
通讯作者: Blackwell TS
The COVID-19 and Cancer Consortium: NCI Administrative Supplement to P30 Cancer Center Support Grant (CCSG)
Strategies to Improve Outcomes for triple negative Breast Cancer Patients involv
  • 批准号:
    8764758
  • 项目类别:
  • 资助金额:
    $28.97万
  • 财政年份:
    2014
  • 负责人:
    JENNIFER A PIETENPOL
  • 依托单位:
p63 and p73 Signaling in Cell Growth and Cancer
  • 批准号:
    8657362
  • 项目类别:
  • 资助金额:
    $2.13万
  • 财政年份:
    2013
  • 负责人:
    JENNIFER A PIETENPOL
  • 依托单位:
Supplement
  • 批准号:
    8754463
  • 项目类别:
  • 资助金额:
    $8.52万
  • 财政年份:
    2013
  • 负责人:
    JENNIFER A PIETENPOL
  • 依托单位:
海外基金